News
Regardless of dose used, povorcitinib use for 24 weeks among patients with extensive nonsegmental vitiligo improved total and facial repigmentation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback